BioLargo, Inc. (BLGO) stock
BLGOOTCChemicals & Allied ProductsFiscal year ends December 31
$0.07+0.00 (+0.90%)
Close on Oct 19, 2026Market cap $23.27MP/E –Yield –
BioLargo ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
BioLargo's ebitda for the twelve months ending Mar 31, 2019 was -$6.41M. For fiscal 2023 it was -$4.48M. The highest annual figure on record is -$2.61M in fiscal 2013.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -$4.48M | – |
| FY2022 | Dec 31, 2022 | -$5.35M | – |
| FY2021 | Dec 31, 2021 | -$6.76M | – |
| FY2020 | Dec 31, 2020 | -$7.53M | – |
| FY2019 | Dec 31, 2019 | -$6.63M | – |
| FY2018 | Dec 31, 2018 | -$6.36M | – |
| FY2017 | Dec 31, 2017 | -$5.87M | – |
| FY2016 | Dec 31, 2016 | -$4.92M | – |
| FY2015 | Dec 31, 2015 | -$4.17M | – |
| FY2014 | Dec 31, 2014 | -$3.38M | – |
| FY2013 | Dec 31, 2013 | -$2.61M | – |
| FY2012 | Dec 31, 2012 | -$4.71M | – |
| FY2011 | Dec 31, 2011 | -$3.15M | – |
| FY2010 | Dec 31, 2010 | -$4.19M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2020 | Mar 31, 2020 | -$1.69M | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.65M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.50M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.65M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.62M | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.59M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.49M | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.49M | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.46M | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.42M | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.19M | – |
| Q3 FY2016 | Sep 30, 2016 | -$1.22M | – |
See a number that looks wrong?